Skip to main content
SpringerLink
Log in

The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome

  • Letter to the Editor
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alby, C., Ben Abdesselam, O., Foglietti, M. J., & Beaudeux, J. L. (2002). Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood. Clinica Chimica Acta, 325(1–2), 183–186.

    Article  CAS  Google Scholar 

  2. Gerlach, R. F., Uzuelli, J. A., Souza-Tarla, C. D., & Tanus-Santos, J. E. (2005). Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Analytical Biochemistry, 344(1), 147–149.

    Article  CAS  Google Scholar 

  3. Jung, K., Laube, C., Lein, M., Lichtinghagen, R., Tschesche, H., Schnorr, D., & Loening, S. A. (1998). Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clinical Chemistry, 44(5), 1060–1062.

    CAS  PubMed  Google Scholar 

  4. Lahdentausta, L., Leskela, J., Winkelmann, A., Tervahartiala, T., Sorsa, T., Pesonen, E., & Pussinen, P. J. (2018). Serum MMP-9 diagnostics, prognostics, and activation in acute coronary syndrome and its recurrence. Journal of Cardiovascular Translational Research, 11(3), 210–220. https://doi.org/10.1007/s12265-018-9789-x.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Santana, I., & Tanus-Santos, J. (2018). Serum or plasma matrix metalloproteinase (MMP)-9 levels and cardiovascular diseases. Journal of Cardiovascular Translational Research.

Download references

Funding

This study was funded by grants from the Finnish Dental Society Apollonia (LL and PJP), Orion Research Foundation (LL), Juhani Aho Medical Foundation (LL), Aarne and Aili Turunen Foundation (LL), the Association of Finnish Female Dentists (LL), the Academy of Finland (#1266053) (PJP), the Sigrid Juselius foundation (PJP), the Aarne Koskelo foundation (PJP), the Päivikki and Sakari Sohlberg foundation (PJP), the Lund University (EP), the Lund University Hospital (EP), the Helsinki University Hospital Research Foundation (TYH 2016251, 2017251, 2018229, Y1149SUL32), and the Karolinska Institutet, Stockholm, Sweden.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki 1, Haartmaninkatu 8, 00290, Helsinki, Finland

    Laura Lahdentausta, Timo Sorsa & Pirkko Pussinen

  2. University of Helsinki, PL 63, 00014, Helsinki, Finland

    Laura Lahdentausta, Timo Sorsa & Pirkko Pussinen

  3. Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden

    Timo Sorsa

  4. Skåne University, Lund, Skåne, Sweden

    Erkki Pesonen

  5. Department of Paediatrics, Division of Paediatric Cardiology, Skåne University Hospital, Lund, Sweden

    Erkki Pesonen

Authors
  1. Laura Lahdentausta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timo Sorsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erkki Pesonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pirkko Pussinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Lahdentausta.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Associate Editor Enrique Lara-Pezzi oversaw the review of this article

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lahdentausta, L., Sorsa, T., Pesonen, E. et al. The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome. J. of Cardiovasc. Trans. Res. 11, 526–527 (2018). https://doi.org/10.1007/s12265-018-9833-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-018-9833-x

Search

Navigation